Nancy Van Osselaer

Nancy Van Osselaer is a highly experienced professional in the life sciences and healthcare sectors, currently serving as the part-time Chief Development Officer at Kynexis since January 2023. In addition to this role, Nancy is a member of the Supervisory Board at Molecure and has established a consultancy, Why2What, focusing on research and development. Previous positions include Vice President of Early Development and Innovation at 2 Bridge, Head of Early Development Project Leaders at Galapagos, and leadership roles at UCB, where innovative solutions in neurology were a focus. Nancy began a substantial career at Johnson & Johnson, holding positions such as Global Project Leader and Site Director of Clinical Pharmacokinetics. Nancy holds a Doctor of Pharmacy degree in Pharmacology from the University of Antwerp.